Tumeur du glomus tympanique : Questions médicales fréquentes
Nom anglais: Glomus Tympanicum Tumor
Descriptor UI:D043604
Tree Number:C04.557.580.625.650.700.705.360
Termes MeSH sélectionnés :
Interrupted Time Series Analysis
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tumeur du glomus tympanique : Questions médicales les plus fréquentes",
"headline": "Tumeur du glomus tympanique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tumeur du glomus tympanique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-07",
"dateModified": "2025-03-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tumeur du glomus tympanique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Paragangliome extrasurrénalien",
"url": "https://questionsmedicales.fr/mesh/D010236",
"about": {
"@type": "MedicalCondition",
"name": "Paragangliome extrasurrénalien",
"code": {
"@type": "MedicalCode",
"code": "D010236",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.580.625.650.700.705"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Tumeur du glomus tympanique",
"alternateName": "Glomus Tympanicum Tumor",
"code": {
"@type": "MedicalCode",
"code": "D043604",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Marc-Olivier Falcone",
"url": "https://questionsmedicales.fr/author/Marc-Olivier%20Falcone",
"affiliation": {
"@type": "Organization",
"name": "Clinique Jouvenet, Capio - Ramsay Santé, 6 Square Jouvenet, 75016 Paris, France; Hôpital Privé Paul d'Egine, Capio - Ramsay Santé, 4 Avenue Marx Dormoy, 94500 Champigny sur Marne, France. Electronic address: falcone.research@gmail.com."
}
},
{
"@type": "Person",
"name": "Hong Wu",
"url": "https://questionsmedicales.fr/author/Hong%20Wu",
"affiliation": {
"@type": "Organization",
"name": "Department of Otorhinolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University; Hunan Provincial Key Laboratory of Major Otorhinolaryngology Diseases; National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Changsha 410008, China. 170966103@qq.com."
}
},
{
"@type": "Person",
"name": "Xing Liu",
"url": "https://questionsmedicales.fr/author/Xing%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Department of Otorhinolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University; Hunan Provincial Key Laboratory of Major Otorhinolaryngology Diseases; National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Changsha 410008, China."
}
},
{
"@type": "Person",
"name": "Xuewen Wu",
"url": "https://questionsmedicales.fr/author/Xuewen%20Wu",
"affiliation": {
"@type": "Organization",
"name": "Department of Otorhinolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University; Hunan Provincial Key Laboratory of Major Otorhinolaryngology Diseases; National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Changsha 410008, China."
}
},
{
"@type": "Person",
"name": "Lisha Wu",
"url": "https://questionsmedicales.fr/author/Lisha%20Wu",
"affiliation": {
"@type": "Organization",
"name": "Department of Otorhinolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University; Hunan Provincial Key Laboratory of Major Otorhinolaryngology Diseases; National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Changsha 410008, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The effect of COVID-19 on workplace violence in California's hospitals: An interrupted time series analysis.",
"datePublished": "2023-02-10",
"url": "https://questionsmedicales.fr/article/36762706",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jan.15588"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hurricane Florence and suicide mortality in North Carolina: a controlled interrupted time-series analysis.",
"datePublished": "2022-12-13",
"url": "https://questionsmedicales.fr/article/36600665",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/ip-2022-044709"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Impact of Drought on HIV Care in Rural South Africa: An Interrupted Time Series Analysis.",
"datePublished": "2023-07-31",
"url": "https://questionsmedicales.fr/article/37523018",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10393-023-01647-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "The effect of vaccine mandate announcements on vaccine uptake in Canada: An interrupted time series analysis.",
"datePublished": "2023-04-03",
"url": "https://questionsmedicales.fr/article/37019696",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.vaccine.2023.03.040"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of febuxostat on adverse events and mortality in gout in Taiwan: An interrupted time series analysis.",
"datePublished": "2023-01-06",
"url": "https://questionsmedicales.fr/article/36608705",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1756-185X.14558"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tumeurs",
"item": "https://questionsmedicales.fr/mesh/D009369"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs par type histologique",
"item": "https://questionsmedicales.fr/mesh/D009370"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs du tissu nerveux",
"item": "https://questionsmedicales.fr/mesh/D009380"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tumeurs neuroectodermiques",
"item": "https://questionsmedicales.fr/mesh/D017599"
},
{
"@type": "ListItem",
"position": 6,
"name": "Tumeurs neuroendocrines",
"item": "https://questionsmedicales.fr/mesh/D018358"
},
{
"@type": "ListItem",
"position": 7,
"name": "Paragangliome",
"item": "https://questionsmedicales.fr/mesh/D010235"
},
{
"@type": "ListItem",
"position": 8,
"name": "Paragangliome extrasurrénalien",
"item": "https://questionsmedicales.fr/mesh/D010236"
},
{
"@type": "ListItem",
"position": 9,
"name": "Tumeur du glomus tympanique",
"item": "https://questionsmedicales.fr/mesh/D043604"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tumeur du glomus tympanique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tumeur du glomus tympanique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tumeur du glomus tympanique",
"description": "Comment diagnostique-t-on une tumeur du glomus tympanique ?\nQuels examens sont nécessaires pour confirmer la tumeur ?\nQuels signes cliniques indiquent une tumeur du glomus tympanique ?\nLa biopsie est-elle nécessaire pour le diagnostic ?\nQuels spécialistes sont impliqués dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D043604?mesh_terms=Interrupted+Time+Series+Analysis&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tumeur du glomus tympanique",
"description": "Quels sont les symptômes courants de cette tumeur ?\nLa douleur est-elle un symptôme fréquent ?\nPeut-on avoir des symptômes sans perte auditive ?\nLes symptômes peuvent-ils varier d'un patient à l'autre ?\nLes symptômes s'aggravent-ils avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D043604?mesh_terms=Interrupted+Time+Series+Analysis&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tumeur du glomus tympanique",
"description": "Peut-on prévenir la tumeur du glomus tympanique ?\nLes facteurs environnementaux jouent-ils un rôle ?\nDes examens réguliers peuvent-ils aider ?\nLes antécédents familiaux influencent-ils le risque ?\nL'exposition au bruit peut-elle être un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D043604?mesh_terms=Interrupted+Time+Series+Analysis&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tumeur du glomus tympanique",
"description": "Quel est le traitement principal pour cette tumeur ?\nLa radiothérapie est-elle utilisée ?\nY a-t-il des traitements médicamenteux disponibles ?\nQuels sont les risques associés à la chirurgie ?\nLe suivi post-opératoire est-il nécessaire ?",
"url": "https://questionsmedicales.fr/mesh/D043604?mesh_terms=Interrupted+Time+Series+Analysis&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tumeur du glomus tympanique",
"description": "Quelles complications peuvent survenir après traitement ?\nLa récidive de la tumeur est-elle possible ?\nDes problèmes d'équilibre peuvent-ils survenir ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications auditives ?",
"url": "https://questionsmedicales.fr/mesh/D043604?mesh_terms=Interrupted+Time+Series+Analysis&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tumeur du glomus tympanique",
"description": "Quels sont les facteurs de risque connus ?\nL'âge influence-t-il le risque de développer cette tumeur ?\nLes femmes sont-elles plus à risque que les hommes ?\nDes maladies préexistantes augmentent-elles le risque ?\nL'exposition à des produits chimiques est-elle un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D043604?mesh_terms=Interrupted+Time+Series+Analysis&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une tumeur du glomus tympanique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, l'audiométrie et l'imagerie (IRM ou scanner)."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour confirmer la tumeur ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une otoscopie et une imagerie avancée comme l'IRM sont essentielles pour confirmer la tumeur."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une tumeur du glomus tympanique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des acouphènes, une perte auditive et parfois des douleurs auriculaires."
}
},
{
"@type": "Question",
"name": "La biopsie est-elle nécessaire pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biopsie n'est généralement pas nécessaire, le diagnostic se fait par imagerie et symptômes."
}
},
{
"@type": "Question",
"name": "Quels spécialistes sont impliqués dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les oto-rhino-laryngologistes (ORL) sont les principaux spécialistes pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de cette tumeur ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent acouphènes, perte auditive, et parfois des vertiges."
}
},
{
"@type": "Question",
"name": "La douleur est-elle un symptôme fréquent ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur n'est pas fréquente, mais elle peut survenir dans certains cas avancés."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans perte auditive ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent présenter des acouphènes sans perte auditive significative."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'un patient à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la combinaison des symptômes peuvent varier selon les individus."
}
},
{
"@type": "Question",
"name": "Les symptômes s'aggravent-ils avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, les symptômes peuvent s'aggraver progressivement."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la tumeur du glomus tympanique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de mesures préventives spécifiques pour cette tumeur."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs environnementaux ne sont pas clairement établis comme causes de cette tumeur."
}
},
{
"@type": "Question",
"name": "Des examens réguliers peuvent-ils aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers chez un ORL peuvent aider à détecter des problèmes précocement."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'y a pas de preuve solide que les antécédents familiaux augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'exposition au bruit peut-elle être un facteur ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition au bruit n'est pas directement liée à l'apparition de cette tumeur."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour cette tumeur ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est la chirurgie pour retirer la tumeur, souvent avec succès."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle utilisée ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie n'est pas couramment utilisée, la chirurgie est le traitement de choix."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements médicamenteux disponibles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitements médicamenteux spécifiques pour cette tumeur."
}
},
{
"@type": "Question",
"name": "Quels sont les risques associés à la chirurgie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des saignements, des infections et des complications auditives."
}
},
{
"@type": "Question",
"name": "Le suivi post-opératoire est-il nécessaire ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est essentiel pour surveiller d'éventuelles récidives."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après traitement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles auditifs, des infections et des vertiges persistants."
}
},
{
"@type": "Question",
"name": "La récidive de la tumeur est-elle possible ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la récidive est possible, surtout si la tumeur n'est pas complètement retirée."
}
},
{
"@type": "Question",
"name": "Des problèmes d'équilibre peuvent-ils survenir ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes d'équilibre peuvent survenir en raison de l'atteinte des structures de l'oreille."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications ne sont pas fréquentes mais peuvent survenir, nécessitant un suivi."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications auditives ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications auditives peuvent être gérées par des appareils auditifs ou des thérapies."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs de risque incluent des antécédents familiaux et des expositions environnementales."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de développer cette tumeur ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, cette tumeur est plus fréquente chez les adultes, généralement entre 30 et 60 ans."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque que les hommes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'y a pas de preuve claire que le sexe influence le risque de cette tumeur."
}
},
{
"@type": "Question",
"name": "Des maladies préexistantes augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies vasculaires peuvent augmenter le risque, mais ce n'est pas systématique."
}
},
{
"@type": "Question",
"name": "L'exposition à des produits chimiques est-elle un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition à certains produits chimiques peut être un facteur, mais les preuves sont limitées."
}
}
]
}
]
}
This study used California's unique Workplace Violent Incident Reporting System (WVIRS) to describe changes in workplace violence (WV) exposure for hospital-based healthcare workers during the pandemi...
Interrupted time series analysis....
We compared the linear trends in weekly WV incidents reported during the period before the COVID-19 pandemic (7/1/2017-3/20/2020) to the period following California's shutdown (3/21/2020-6/30/2021). W...
A total of 418 hospitals reported 37,561 incidents during the study period. For EDs, the number of reported incidents remained essentially constant, despite a 26% drop in outpatient visits between the...
WV persists steadily in California's hospitals. Despite major reductions in patient volume due to COVID-19, weekly reported ED incidents remained essentially unchanged....
Surveys and media reported that WV increased during the pandemic, but it has been difficult to measure these changes using a large-scale database. The absolute number of WV incidents did not increase ...
There was no public contribution to this study. The goal of this analysis was to summarize findings from administrative data. The findings presented can inform future discussion of public policy and a...
Natural disasters are associated with increased mental health disorders and suicidal ideation; however, associations with suicide deaths are not well understood. We explored how Hurricane Florence, wh...
We used publicly available NC death records data to estimate associations between Hurricane Florence and monthly suicide death rates using a controlled, interrupted time series analysis. Hurricane exp...
8363 suicide deaths occurred between January 2014 and December 2019. The overall suicide death rate in NC between 2014 and 2019 was 15.53 per 100 000 person-years (95% CI 15.20 to 15.87). Post-Hurrica...
Although results did not indicate a strong post-Hurricane Florence impact on suicide rates, subgroup analysis suggests differential impacts of Hurricane Florence on several groups, warranting future f...
This analysis investigates the relationship between drought and antiretroviral treatment (ART) adherence and retention in HIV care in the Hlabisa sub-district, KwaZulu-Natal, South Africa. Data on dro...
In 2021, the ten provinces in Canada enacted COVID-19 vaccine mandates that restricted access to non-essential businesses and services to those that could provide proof of full vaccination to decrease...
Aggregated data from the Canadian COVID-19 Vaccination Coverage Surveillance System (CCVCSS) were used to measure vaccine uptake (defined as the weekly proportion of individuals who received at least ...
The times series models demonstrated significant increases in vaccine uptake following mandate announcement in BC, AB, SK, MB, NS, and NL. No trends in the effect of mandate announcements were observe...
Vaccine mandate announcements could have increased vaccine uptake. However, it is difficult to interpret this effect within the larger epidemiological context. Effectiveness of the mandates can be aff...
To evaluate the influence of febuxostat on adverse events and mortality in gout....
We retrospectively enrolled patients with newly diagnosed gout and prescribed urate-lowering therapy between 2006 and 2017 from the Taiwan National Health Insurance Database. These patients were divid...
The proportion of febuxostat use gradually increased from 0% in 2012 to 30% in those with comorbidities and 10% in those without comorbidities in 2017. Allopurinol use decreased from 30% in 2012 to 10...
Febuxostat may reduce SJS and TEN in all gout patients but increase AMI, PCI, and all-cause mortality in gout patients with comorbidities....
To determine death occurrences of Puerto Ricans on the mainland USA following the arrival of Hurricane Maria in Puerto Rico in September 2017....
Cross-sectional study....
Persons of Puerto Rican origin on the mainland USA....
Hurricane Maria....
We use an interrupted time series design to analyse all-cause mortality of Puerto Ricans in the USA following the hurricane. Hispanic origin data from the National Vital Statistics System and from the...
We found an increase in mortality for persons of Puerto Rican origin during the 6-month period following the hurricane (October 2017 through March 2018), suggesting that deaths among these persons wer...
Our findings suggest an undercounting of previous deaths as a result of the hurricane due to the systematic effects on the displaced and resident populations in the mainland USA. Displaced populations...
The growth of parkrun between 2004 and 2019 has been heralded as a success story for public health as a result of its physical activity and wellbeing benefits for participants. However, parkrun was no...
The study combines aggregated parkrun weekly finisher data from 32,470 Lower Layer Super Output Areas (LSOA) in England from January 2015 to February 2023 with Office of National Statistics (ONS) data...
Visualisation and interrupted time series analysis showed a significant and long-term decrease in parkrun participation following the reopening of parkrun events. This was consistent across all IMD qu...
The reduction in parkrun participation during the pandemic and following the reopening of events is likely to have negatively impacted wellbeing in would-be participants. Going forwards, policymakers ...
To analyze epidemiological characteristics of mumps in different periods and explore the impact of different immunization strategies of mumps containing vaccine (MuCV) on the incidence of mumps in Quz...
Beverage and food taxes have become a popular 'best buy' public health intervention in the global battle to tackle noncommunicable diseases. Though many countries have introduced taxes, mainly targeti...
We used weekly electronic point-of-sale data from a major food retailer in Bermuda. We assessed historical weekly sales and price data using an interrupted time series design on 2,703 unique products ...
By January 2020, the average price per ounce of SSBs increased by 26.0%, while the price of untaxed beverages (including waters and non-added sugar drinks) remained constant. The increasing price of S...
The tax was largely passed through to consumers. However, several factors mitigated the impact of the tax on the prices paid for SSBs by consumers, including the specific design of the tax, price prom...
To assess the trends in medication use indicative of physical and psychological morbidity following the 2010 volcanic eruption in Eyjafjallajökull immediately after and during a 3-year period followin...
Population-based register study....
Eyjafjallajökull eruption in Iceland, 2007-2013....
All residents in Iceland who received at least one medication dispensing were identified. Residents of exposed areas were classified into exposure groups (individual-level data) and residents in other...
Eyjafjallajökull erupted on 14 April 2010 and continued for 39 days, producing heavy ash fall in South Iceland....
Using interrupted time series analysis, we examined annual and quarterly changes in medicine use, measured as number of dispensed defined daily dose (DDD) per 1000 individuals. We calculated the level...
Among exposed residents, there was a 6% decrease (95% CI -7% to -4%) in the annual number of dispensed DDDs 1-year post-eruption in the overall medication class, including analgesics (-5%, 95% CI -6% ...
Our findings indicate that the eruption did not lead to increases in medication dispensing among residents of exposed areas, rather decreases for some medicine classes. The results should be interpret...
